Sumatriptan
Sold as Imigran nasal, Sumig, Triptam, Imigen, Wixaplax, Austigran, Austell sumatriptan, Sumagran, Ran-sumatriptan, Migo, Auro-sumatriptan, Adco-sumatriptan, Surogran, Migrex otc, Migrex, Imigran
1-[3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl]-N-methylmethanesulfonamide
Drag to rotate. Structure from PubChem CID 5358.
Background
Registration
- Applicants
- 10
- Registrations
- 27
- Schedule source
- SAHPRA documentation
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Glaxosmithkline South Africa (Pty) LimitedCancelled | Imigran nasal, Imigran | 20 mg, injection | 310197, Z0011 | Not determined | None |
| Cipla Medpro (Pty) LtdCancelled | Sumig | 50, 100 | 410089, 410090 | Not determined | None |
| Pharmacare limited û woodmeadCancelled | Triptam | 50 mg, 100 mg | 410244, 410245 | Not determined | None |
| Viatris Healthcare (Pty) Ltd | Imigen | 50, 100 | 410321, 410322 | Not determined | None |
| Trinity Pharma (Pty) Ltd | Wixaplax | 50 mg, 100 mg | 410360, 410361 | Not determined | None |
| Austell Pharmaceuticals (Pty) Ltd | Austigran, Austell sumatriptan, Sumagran | 50 mg, 100 mg | 410477, 410478, 410479, 410480, 410481, 410482 | Not determined | None |
| MSQ Pharma (Pty) Ltd | Ran-sumatriptan, Migo | 50, 100 | 410676, 410677, 410678, 410679 | Not determined | None |
| Aurogen South Africa (Pty) Ltd | Auro-sumatriptan, Surogran | 50 mg, 100 mg | 420269, 420270, 420367, 420368 | Not determined | None |
| Adcock ingram limitedCancelled | Adco-sumatriptan | 100 | 420353 | Not determined | None |
| Sandoz South Africa (Pty) LtdCertificate held by Sandoz SA (Pty) Ltd1 | Migrex otc, Migrex | 50 mg | A380507, A380508 | S2 | PIPIL |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Imigran 20 MG nasal spray EACH UNIT DOSE CONTAINS SUMATRIPTAN 20,0 mg | 20 mgSpray | 31019731/7.3/0197 | Cancelled | Not determined | None |
| Sumig 50 EACH TABLET CONTAINS SUMATRIPTAN SUCCINATE EQUIVALENT TO SUMATRIPTAN 50,0 mg | 50 | 41008941/7.3/0089 | Cancelled | Not determined | None |
| Sumig 100 EACH TABLET CONTAINS SUMATRIPTAN SUCCINATE EQUIVALENT TO SUMATRIPTAN 100,0 mg | 100 | 41009041/7.3/0090 | Cancelled | Not determined | None |
| Triptam 50 MG EACH TABLET CONTAINS SUMATRIPTAN SUCCINATE EQUIVALENT TO SUMATRIPTAN 50,0 mg | 50 mg | 41024441/7.3/0244 | Cancelled | Not determined | None |
| Triptam 100 MG EACH TABLET CONTAINS SUMATRIPTAN SUCCINATE EQUIVALENT TO SUMATRIPTAN 100,0 mg | 100 mg | 41024541/7.3/0245 | Cancelled | Not determined | None |
| Imigen 50 EACH TABLET CONTAINS SUMATRIPTAN SUCCINATE EQUIVALENT TO SUMATRIPTAN 50,0 mg | 50 | 41032141/1.2/0321 | Registered | Not determined | None |
| Imigen 100 EACH TABLET CONTAINS SUMATRIPTAN SUCCINATE EQUIVALENT TO SUMATRIPTAN 100,0 mg | 100 | 41032241/1.2/0322 | Registered | Not determined | None |
| Wixaplax 50 MG EACH TABLET CONTAINS SUMATRIPTAN SUCCINATE EQUIVALENT TO SUMATRIPTAN 50,0 mg | 50 mg | 41036041/1.2/0360 | Registered | Not determined | None |
| Wixaplax 100 MG EACH TABLET CONTAINS SUMATRIPTAN SUCCINATE EQUIVALENT TO SUMATRIPTAN 100,0 mg | 100 mg | 41036141/1.2/0361 | Registered | Not determined | None |
| Austigran-50 EACH TABLET CONTAINS SUMATRIPTAN SUCCINATE EQUIVALENT TO SUMATRIPTAN 50,0 mg | 50 | 41047741/7.3/0477 | Registered | Not determined | None |
| Austigran-100 EACH TABLET CONTAINS SUMATRIPTAN SUCCINATE EQUIVALENT TO SUMATRIPTAN 100,0 mg | 100 | 41047841/7.3/0478 | Registered | Not determined | None |
| Austell sumatriptan 50 MG EACH TABLET CONTAINS SUMATRIPTAN SUCCINATE EQUIVALENT TO SUMATRIPTAN 50,0 mg | 50 mg | 41047941/7.3/0479 | Registered | Not determined | None |
| Austell sumatriptan 100 MG EACH TABLET CONTAINS SUMATRIPTAN SUCCINATE EQUIVALENT TO SUMATRIPTAN 100,0 mg | 100 mg | 41048041/7.3/0480 | Registered | Not determined | None |
| Sumagran-50 EACH TABLET CONTAINS SUMATRIPTAN SUCCINATE EQUIVALENT TO SUMATRIPTAN 50,0 mg | 50 | 41048141/7.3/0481 | Registered | Not determined | None |
| Sumagran-100 EACH TABLET CONTAINS SUMATRIPTAN SUCCINATE EQUIVALENT TO SUMATRIPTAN 100,0 mg | 100 | 41048241/7.3/0482 | Registered | Not determined | None |
| Ran-sumatriptan 50 EACH TABLET CONTAINS SUMATRIPTAN SUCCINATE EQUIVALENT TO SUMATRIPTAN 50,0 mg | 50 | 41067641/7.3/0676 | Registered | Not determined | None |
| Ran-sumatriptan 100 EACH TABLET CONTAINS SUMATRIPTAN SUCCINATE EQUIVALENT TO SUMATRIPTAN 100,0 mg | 100 | 41067741/7.3/0677 | Registered | Not determined | None |
| Migo 50 EACH TABLET CONTAINS SUMATRIPTAN SUCCINATE EQUIVALENT TO SUMATRIPTAN 50,0 mg | 50 | 41067841/7.3/0678 | Registered | Not determined | None |
| Migo 100 EACH TABLET CONTAINS SUMATRIPTAN SUCCINATE EQUIVALENT TO SUMATRIPTAN 100,0 mg | 100 | 41067941/7.3/0679 | Registered | Not determined | None |
| Auro-sumatriptan tablets 50 MG EACH TABLET CONTAINS SUMATRIPTAN SUCCINATE EQUIVALENT TO SUMATRIPTAN 50,0 mg | 50 mgTablets | 42026942/7.3/0269 | Registered | Not determined | None |
| Auro-sumatriptan tablets 100 MG EACH TABLET CONTAINS SUMATRIPTAN SUCCINATE EQUIVALENT TO SUMATRIPTAN 100,0 mg | 100 mgTablets | 42027042/7.3/0270 | Registered | Not determined | None |
| Adco-sumatriptan 100 EACH TABLET CONTAINS SUMATRIPTAN SUCCINATE EQUIVALENT TO SUMATRIPTAN 100,0 mg | 100 | 42035342/7.3/0353 | Cancelled | Not determined | None |
| Surogran 50 MG EACH TABLET CONTAINS SUMATRIPTAN SUCCINATE EQUIVALENT TO SUMATRIPTAN 50,0 mg | 50 mg | 42036742/7.3/0367 | Registered | Not determined | None |
| Surogran 100 MG EACH TABLET CONTAINS SUMATRIPTAN SUCCINATE EQUIVALENT TO SUMATRIPTAN 100,0 mg | 100 mg | 42036842/7.3/0368 | Registered | Not determined | None |
| Migrex otc EACH TABLET CONTAINS SUMATRIPTAN SUCCINATE EQUIVALENT TO SUMATRIPTAN 50,0 mg | Not listed | A380507A38/7.3/0507 | Registered | Not determined | None |
| Migrex 100 EACH TABLET CONTAINS SUMATRIPTAN SUCCINATE EQUIVALENT TO SUMATRIPTAN 100,0 mg | 50 mgTablet | A380508A38/7.3/0508Approved 18 January 2022 | Registered | S2 | PIPIL |
| Imigran injection EACH SYRINGE CONTAINS SUMATRIPTAN SUCCINATE EQUIVALENT TO 6 mg SUMATRIPTAN | Injection | Z0011Z/7.3/11 | Cancelled | Not determined | None |
Regulatory status
Where S2 sits on the scale
A pharmacist can sell it directly, without a prescription.
Schedule 2 medicines sit behind the pharmacy counter. A pharmacist can decide to sell one of these directly, using their own professional judgement, without a doctor's prescription. It can also be dispensed against a prescription like the higher tiers, in which case the usual repeat limits apply. A child under 12 may only be sold a Schedule 2 substance on a prescription, or on a written order that names the purpose and carries a signature the seller recognises. Even though it cannot be advertised to the public in the ordinary sense, its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S2, read from the product's PI-PIL leaflet.
The Consolidated Schedules list this ingredient up to S4; the leaflet's S2 applies to this product.
Who may supply: Only a pharmacist, pharmacist intern or supervised pharmacist's assistant may sell it without a prescription. It may otherwise be dispensed by a pharmacist against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Sumatriptan succinate equivalent to sumatriptan
S4: Sumatriptan
- except when in oral solid dosage forms providing 50 mg or less and presented as packs of no more than two oral solid dosage forms, indicated for the acute relief of migraine attacks, with or without aura, in patients previously diagnosed by a medical practitioner and initiated on treatment with sumatriptan. (S2)
Consolidated Schedules 06 July 2026, lines 8060 to 8062
S2: Sumatriptan
- when in oral solid dosage forms providing 50 mg or less and presented as packs of no more than two oral solid dosage forms, indicated for the acute relief of migraine attacks, with or without aura, in patients previously diagnosed by a medical practitioner and initiated on treatment with sumatriptan. (S4)
Consolidated Schedules 06 July 2026, lines 2683 to 2685
Pharmacological class: Migraine preparations. (class 7.3)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
Migrex 100, Sandoz South Africa (Pty) Ltd is scheduled S2 in its official SAHPRA documents, read with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.